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Polymorphonuclear leukocyte function was evaluated in vitro after in vivo
administration of a single dose of dexamethasone to cattle. Purified polymorpho-
nuclear leukocytes from dexamethasone-treated cattle displayed enhanced ran-
dom migration under agarose but impaired ingestion of Staphylococcus aureus,
Nitro Blue Tetrazolium reduction, chemiluminescence, iodination, and antibody-
dependent, cell-mediated cytotoxicity. The depression of iodination may have
been related to a drop in the proportion of eosinophils present in the polymor-
phonuclear leukocyte preparations after dexamethasone administration.
Glucocorticoids, when administered to hu-
mans or animals, have been observed to decrease
the inflammatory response and to predispose to
bacterial infection (9). Polymorphonuclear leu-
kocytes (PMNs) play an important role in both
the inflammatory response and the control of
bacterial infection. For this reason, numerous
investigations have been conducted on the ef-
fects of glucocorticoids on PMN function. There
are many reports of defects in PMN function
after in vitro or in vivo exposure to glucocorti-
coids. However, it is difficult to reach a conclu-
sion on the overall effects of glucocorticoid ther-
apy on PMN function owing to conflicting re-
sults and variations in experimental techniques.
One potential reason for conflicting results when
PMNs are exposed in vitro to glucocorticoids is
that, in some experiments, the succinate form of
glucocorticoids was used (8, 13, 17). The succi-
nate must be split off in the liver by an esterase
before the drug is active. Spontaneous cleavage
of the succinate under in vitro conditions occurs
slowly. With extremely high concentrations of
the succinate compound enough free glucocor-
ticoid may be present to affect PMN function
(3, 19, 21). Another possible explanation for the
presence of conflicting results when comparing
the in vitro and in vivo exposure of PMNs to
glucocorticoids is that in vivo administration of
glucocorticoids may have indirect effects on
PMN function by altering the activity of other
mediators of inflammation. For example, beta-
methasone has been shown to block prostacyclin
synthesis by vascular endothelial cells (16). Pros-
tacyclins may have potent effects on PMN func-
tion (31). For these reasons, it is desirable to
design experiments with in vivo treatment of
healthy individuals with glucocorticoids to ob-
tain information relative to the effects of thera-
peutic glucocorticoid administration on PMN
function.
Some of the reports of in vivo treatment with
glucocorticoids have compared PMNs from pa-
tients who are on glucocorticoid therapy for an
underlying pathological process to PMNs ob-
tained from normal individuals (3, 4, 27). It is
difficult to be certain whether the defects in
PMN function observed are due to glucocorti-
coid treatment or to the underlying pathologic
process. There are reports comparing the func-
tion of PMNs from normal subjects who have
voluntarily received a therapeutic dosage of glu-
cocorticoid to that of normal controls (6, 18).
This has yielded important information, but
only one or two aspects of PMN function have
been evaluated.
Glucocorticoids are extensively used thera-
peutically in cattle, but their effects on the im-
mune system are not well characterized. Dexa-
methasone is a potent glucocorticoid which is
commonly administered to cattle for the induc-
tion of parturition, the alleviation of physiologi-
cal udder edema, the reduction of musculoskel-
etal inflammation, and the treatment of ketosis
(15). Dexamethasone administration to cattle
has been observed to have serious detrimental
consequences such as the recrudescence of infec-
tious bovine rhinotracheitis virus (10, 11, 22),
the predisposition to a fatal viremia in bovine
viral diarrhea virus-infected calves (26), and a
more severe disease course when administered
to cattle suffering from bronchial pneumonia (5).
The observed potentiation of infectious pro-
cesses indicates that dexamethasone suppresses
the bovine immune system. Dexamethasone has
previously been shown to suppress mitogen-in-
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duced bovine lymphocyte blastogenesis (10, 20)
which is considered an in vitro correlate of in
vivo cell-mediated immunity.
The purpose of the experimentation reported
here was to determine the effects of a pharna-
cological dose ofdexamethasone on bovine PMN
function. Six different functional parameters
were evaluated on PMNs which were obtained
from control and dexamethasone-treated cattle.
All six tests were performed within, a few hours
of the time that the blood sample was drawn so
that the results could be accurately compared.
MATERIALS AND METHODS
Animals and dexamethasone treatment. Ap-
parently healthy adult Holstein-Friesian steers and
bulls were used. Five animals served as controls, and
seven animals were injected intramuscularly with 40
mg of dexamethasone (0.058 to 0.088 mg/kg of Azium;
Schering Corp., Kenilworth, N.J.). Blood samples were
obtained before and at 2 h and 1, 2, 3, 7, 9, 10, and 13
days after dexamethasone administration for the eval-
uation of PMN function. The experimentation was
conducted with groups consisting of two control ani-
mals and two or three dexamethasone-treated animals.
PMN isolation. PMNs were isolated as previously
described (22a). Briefly, peripheral blood was collected
into acid-citrate-dextrose solution and centrifuged,
and the plasma and buffy coat layer were discarded.
The packed erythrocytes were lysed with distilled
water, and the remaining cells, which generally con-
sisted of greater than 90% granulocytes, were washed
and suspended in 0.015 M phosphate-buffered saline
solution (pH 7.2) to a concentration of 5.0 x 107 PMNs
(neutrophils plus eosinophils) per ml. The cells were
held at room temperature and were used in all six
PMN function tests within 3 h of the time they were
standardized.
PMN function tests. The procedures for evaluat-
ing PMN function have been described in detail else-
where (22a; Roth and Kaeberle, J. Immunol. Methods,
in press). All PMN function tests were conducted in
duplicate. Random migration under agarose was eval-
uated by measuring the area of PMN migration away
from wells in the agarose after an overnight incubation
at 37°C (22a). Heat-killed [lnI]iododeoxyuridine-la-
beled Staphylococcus aureus was used to evaluate
ingestion by PMNs (22a). Opsonized l"I-labeled S.
aureus and PMNs were incubated together at 37°C
with a bacterium/PMN ratio of 60:1. The extracellular
S. aureus was removed by lysostaphin treatment, and
the amount of PMN-associated radioactivity was de-
termined. The results are expressed as the percentage
of the '"I-labeled S. aureus which was ingested. The
quantitative Nitro Blue Tetrazolium (NBT) reduction
assay was performed by adding 5.0 x 106 granulocytes
to a suspension of opsonized zymosan in 1.0 ml of
Earle balanced salt solution containing 0.4 mg ofNBT
(22a). After a 5.0-min incubation at 37°C the reaction
was stopped, the purple formazan formed by the re-
duction of NBT was extracted with pyridine, and the
optical density at 580 nm was determined. The results
are expressed as optical density per 5.0 x 106 PMNs
per 5 min in 5.0 ml of pyridine. Chemiluminescence
was measured in a liquid scintillation spectrometer as
previously described (22a), and the results are ex-
pressed as net counts per hour. Test vials contained
5.0 mg of preopsonized zymosan and 107 PMNs in a
total volume of 10.0 ml of Geys balanced salt solution.
The standard reaction mixture for the determination
of stimulated iodination contained 2.5 x 106 PMNs,
0.05 ,uCi of "2I, 40 nmol of NaI, and 0.5 mg of opsonized
zymosan in 0.5 ml of Earle balanced salt solution (22a).
The reaction was allowed to proceed for 20 min at
37°C, and then the amount of trichloroacetic acid-
precipitable radioactivity was determined. The results
are expressed as nanomoles of NaI per 107 PMNs per
hour. The antibody-dependent, cell-mediated cytotox-
icity (ADCC) assay was performed by utilizing 61Cr-
labeled chicken erythrocytes as target cells (Roth and
Kaeberle, J. Immunol. Methods, in press). The reac-
tion mixture contained 2.5 x 105 51Cr-labeled chicken
erythrocytes and 2.5 x 106 PMNs (effector/target cell
ratio of 10:1) in 0.5 ml of medium 199 containing 10%
bovine anti-chicken erythrocyte serum. Triton X-100
controls, antibody controls, and PMN controls were
included. After 3.0 h of incubation at 37°C, the reac-
tion tubes were centrifuged, and a sample of supema-
tant solution was removed for gamma counting. The
results are expressed as percentages of specific 5"Cr
release.
Statistical differences were calculated by using Stu-
dent's t test and one degree of freedom per blood
sample.
RESULTS
Dexamethasone treatment caused a marked
increase in random migration by bovine PMNs
(Fig. 1). The average area of random migration
was slightly increased at 2 h postinjection and
had doubled by 24 h postinjection. Random
migration by PMNs had returned to within nor-
mal limits by 72 h after dexamethasone admin-
istration.
The ability of PMNs from dexamethasone-
treated animals to ingest S. aureus was mark-
edly depressed at 24 h postinjection (Fig. 2). By
48 h postinjection the ingestion ability had re-
turned to within normal limits. At 10 days post-
injection the ability ofPMNs to ingest S. aureus
was significantly enhanced.
Dexamethasone treatment markedly sup-
pressed NBT reduction by PMNs (Fig. 3). The
suppression was apparent by 2 h postinjection
and remained for several days. Chemilumines-
cence, another parameter of the oxidative me-
tabolism of the PMN, showed a similar pattern
of suppression after dexamethasone treatment
(Fig. 4).
lodination by PMNs isolated from dexameth-
asone-treated cattle was somewhat depressed by
2 h postinjection (Fig. 5). By 24 h postinjection,
the iodination value was less than 50% ofnormal.
The iodination value remained at approximately
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FIG. 1. Effect of in vivo dexamethasone administration on the area ofrandom migration by bovine PMNs
under agarose. The control value is the mean ofa total of49 (n) PMNpreparations from five normal animals;
a, ±1 standard error of the mean; b, ±1 standard deviation. The results for the dexamethasone group are the
mean ± the standard error for seven animals at each time period. Statistically significant differences for the
dexamethasone-treated animals are as indicated. **, P < 0.01.
- - - Controls
- Dexamethasone treat d
b
2 40
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8 10 12 14
Days postinjection
FIG. 2. Effect of in vivo dexamethasone administration on the ingestion of '25I-labeled S. aureus by bovine
PMNs. Values and statistically significant differences are as in Fig. 1, except that n = 47 for the control
group. *, 0.01 < P < 0.005.
50% of normal for the entire 13-day period after
a single injection of dexamethasone.
ADCC by PMNs was somewhat depressed at
2 h and was markedly depressed at 24 h postin-
jection (Fig. 6). By 48 h postinjection it had
returned to near normal levels.
The percentage of eosinophils in the PMN
preparations was markedly reduced after dexa-
methasone administration and remained low for
the entire 13-day period (Fig. 7).
DISCUSSION
A single pharmacological dose of dexametha-
sone administered to normal cattle had a pro-
found effect on PMN function. Dexamethasone
administration caused an enhancement of ran-
dom migration (chemokinesis) by the PMNs but
a depression of ingestion, oxidative metabolism,
the myeloperoxidase -H202- halide antibac-
terial system, and ADCC by PMNs.
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FIG. 3. Effect of in vivo dexamethasone administration on the reduction of Nitro Blue Tetrazolium by
bovine PMNs. Values and statistically significant differences are as in Fig. 1, except that n = 48 for the
control group. *, 0.01 < P < 0.005.
-- - Controls
Dexamethasone treated
2 4
2hr Days postinjection
FIG. 4. Effect of in vivo dexamethasone administration on chemiluminescence by bovine PMNs. Values
and statistically significant differences are as in Fig. 1, except that n = 47 for the control group. *, 00.1 < P
< 0.005.
The stimulation of random migration ob-
served after dexamethasone administration is
similar to results reported for PMNs from hu-
man patients being treated with prednisolone
for various pathological conditions (27-29). Ste-
venson et al. demonstrated that the enhance-
ment of migration was indirect and due to a
mononuclear phagocyte-produced peptide fac-
tor which stimulated PMN migration (27-29). It
is not known whether the increase in PMN
random migration which we observed was me-
diated through an effect of dexamethasone on
mononuclear leukocytes or whether the dexa-
methasone had a direct stimulatory effect on
PMN migration.
There are conflicting reports on the effect of
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FIG. 5. Effect of in vivo dexamethasone administration on iodination by bovine PMNs. Values and
statistically significant differences are as in Fig. 1, except that n = 50 for the control group.
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FIG. 6. Effect on in vivo dexamethasone administration onADCC by bovine PMNs. Values and statistically
significant differences are as in Fig. 1, except that n = 39 for the control group, and there were five animals
in the dexamethasone group.
corticosteroids on ingestion by human PMNs.
Corticosteroids have been reported to inhibit
ingestion by PMNs (8, 13) and to have no effect
on ingestion (3, 17). These discrepancies may be
due to differing techniques for evaluating inges-
tion or to differing amounts and types of corti-
costeroids used. None of these reports involved
the in vivo administration of a pharmacological
dose of corticosteroid to a normal individual.
Our results indicate that a single pharmacologi-
cal dose of dexamethasone administered in vivo
will inhibit ingestion by bovine PMNs. The S.
aureus assay performed here evaluates the ini-
tial rate of ingestion rather than the capacity for
(-
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35
--- Controls
I Dexamethasone treated
a
0 2 4 6 8
2hr Days postinjection
FIG. 7. Effect of in vivo dexamethasone administration on the percent of cells in the purified PMN
preparation which are eosinophils. Values and statistically significant differences are as in Fig. 1, except that
n - 50 for the control group. *, 0.01 < P < 0.005.
ingestion (22a). There is no apparent explana-
tion for the observed increase in S. aureus inges-
tion 10 days after dexamethasone administra-
tion. This increase in PMN function was noted
on only 1 day in only one of the PMN function
tests and was of only marginal statistical signif-
icance. We feel that the data are not sufficient
to attach any importance to this observation.
Our results also demonstrate that dexameth-
asone administration inhibits NBT reduction
and chemiluminescence, two parameters of
PMN oxidative metabolism. Inhibition of NBT
reduction has been reported previously after in
vitro treatment ofhuman PMNs with hydrocor-
tisone (3, 17) and in PMNs from patients with
pathological processes who were being treated
with corticosteroids (3, 4). The depression of
NBT reduction and chemiluminescence indi-
cated that an important component of the
PMNs bactericidal mechanism is impaired by
dexamethasone ainistration (1, 2).
Dexamethasone administration caused a dra-
matic, prolonged depression of iodination by the
bovine PMN preparations. The in vitro treat-
ment of human PMNs with high dosages of
dexamethasone has also been reported to inhibit
iodination (8). The iodination reaction is a mea-
sure of the activity of the myeloperoxidase-hy-
drogen peroxide-halide antibacterial system in
the PMN and it may be depressed by an inhi-
bition of PMN ingestion, oxidative metabolism,
or degranulation (14). Our results indicate that
PMN ingestion and oxidative metabolism are
inhibited by dexamethasone. However, the pro-
longed suppression of iodination (Fig. 5) as com-
pared with S. aureus ingestion (Fig. 2), NBT
reduction (Fig. 3), and chemiluminescence (Fig.
4) suggests that another mechanism is partially
responsible. The PMN preparations used in this
study contained a mixed population of eosino-
phils and neutrophils. Eosinophils in the periph-
eral blood of normal cattle may make up from
2% to 20% of the total leukocyte population (25);
this results in a fairly high percentage of eosin-
ophils in the purified PMN preparations from
normal animals (an average of 22.7% in this
study). Corticosteroid administration causes eo-
sinophils to sequester in lymphoid tissues (24)
and thereby reduces the number of circulating
eosinophils in the peripheral blood. This results
in PMN preparations from dexamethasone-
treated animals with a very low percentage of
eosinophils (Fig. 7). The depression ofiodination
(Fig. 5) seems to parallel the depletion of eosin-
ophils in the PMN preparation (Fig. 7). We have
shown that bovine eosinophils are four to five
times more active than bovine neutrophils in the
stimulated iodination reaction (Roth and Kae-
berle, J. Immunol. Methods, in press). There-
fore, the depression of iodination is probably
mainly due to the lowered percentage of eosin-
ophils in the PMN preparation. We believe that
the early depression of iodination was partially
due to a direct effect of dexamethasone on the
30-
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iodination ability of the neutrophils and not
totally due to a reduction in eosinophil numbers.
In other experimentation we have demonstrated
that administration of adrenocorticotropic hor-
mone to cattle with very low numbers of eosin-
ophils in their peripheral blood resulted in a
depression of iodination by PMNs without a
corresponding decrease in eosinophil numbers
(J. A. Roth, M. L. Kaeberle, and W. H. Hsu,
Am. J. Vet. Res., in press).
The inhibition of ingestion, oxidative metab-
olism, and ADCC by PMNs after dexametha-
sone administration is probably not due to the
decreased percentage of eosinophils because: (i)
we have shown that eosinophils are less efficient
than neutrophils at ingestion of S. aureus and
ADCC, and the two cell types produce equiva-
lent NBT reduction (Roth and Kaeberle, J. Im-
munol. Methods, in press), and (ii) these param-
eters returned to normal within a few days,
whereas iodination and the percentage of eosin-
ophils remained depressed for the entire period
of the study.
Bovine neutrophils have been demonstrated
to be the most active bovine cell type tested in
mediating ADCC against herpesvirus-infected
target cells (23). The exact mechanism of this
cytotoxicity is not known, but it is not dependent
upon deoxyribonucleic acid, ribonucleic acid, or
protein synthesis within the PMN (7, 30), and
seems to require direct cell membrane contact
(12). The results observed here of depressed
ADCC mediated by PMNs after the in vivo
administration of dexamethasone support the
previous report of depressed ADCC by bovine
PMNs treated in vitro with dexamethasone (30).
This inhibition of the ability of PMNs to me-
diate ADCC may play an important role in
allowing bovine herpesvirus, which has been
recrudesced by the administration of dexameth-
asone, to multiply (10, 11, 22).
In summary, a single pharmacological dose of
dexamethasone administered to cattle caused an
enhancement of random migration by PMNs
but an impairment of (i) the ingestion of bacteria
by PMNs, (ii) the oxidative metabolism of the
PMN, (iii) the myeloperoxidase-hydrogen per-
oxide-halide antibacterial system of the PMN,
and (iv) antibody-dependent, PMN-mediated
cytotoxicity. The impairment of PMN function
may at least partially explain the detrimental
effects associated with dexamethasone adminis-
tration to cattle (5, 11, 26).
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